Company: IMRX
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001790340-25-000135
Chunk: 331

Company: Immuneering Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 5
Chunk 331
---
Table of Contents

Item 5. Other Information

(a) Disclosure in lieu of reporting on a Current Report on Form 8-K.

      None.

(b) Material changes to the procedures by which security holders may recommend nominees to the board of directors.

      None.

(c) Insider Trading Arrangements and Policies

During the three months ended September 30, 2025, no director or “officer” (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”, as each term is defined in Item 408(a) of Regulation S-K.